Neisseria meningitidis polysaccharide capsule — Drug Target

All drugs that target Neisseria meningitidis polysaccharide capsule — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Conjugate vaccine

Marketed (1)

• Meningococcal Polysaccharide Diphtheria Toxoid Conjugate · Sanofi Pasteur, a Sanofi Company · Conjugate vaccine · Immunology / Infectious Disease
  This conjugate vaccine stimulates the immune system to produce antibodies against meningococcal polysaccharide capsules by linking them to diphtheria toxoid as a carrier protein.

Phase 3 pipeline (1)

• Meningococcal Polysaccharide Diphtheria Conjugate Vaccine · Sanofi Pasteur, a Sanofi Company · Conjugate vaccine · Immunology / Infectious Disease
  This vaccine stimulates the immune system to produce antibodies against meningococcal polysaccharide antigens by conjugating them to diphtheria toxoid, enhancing immunogenicity and immune memory.